GLP-1 receptor agonists have been studied in recent years on cardiovascular disease and endothelial dysfunction [18], and its treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction [19]. This evidence concerns the gene GLP1R and endothelial dysfunction.